Relaxin Therapy for Atrial Fibrillation

Clinical trial NCT07359872 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07359872
Sponsor: Deeptankar DeMazumder
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Atrial Fibrillation (AF)Arrhythmia Oxidative Stress Stroke Major Cardiovascular Event Heart Failure Catheter Ablation Ablation of Atrial Fibrillation

Start date: 2027-01-01
Primary completion: 2030-12-31
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.